We therefore determined the IRF8 promoter methylation status by MSP and analyzed the correlation between methylation status and clinicopathological features in primary breast cancer samples (n = 114) and surgical-margin tissues (n = 12). This evidence concerns the gene IRF8 and breast carcinoma.